Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Goodman

Showing results (141-150 of 526) with videos related to

Pageof 53
Sort By:
Journal of Obsessive-Compulsive and Related Disorders|February 23, 2022
Obsessive compulsive disorder during the COVID-19 pandemic: A brief review of course, psychological assessment and treatment considerationsCaitlyn E Maye, Katharine D Wojcik, Abigail E Candelari, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1990
Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorderP L Delgado, W K Goodman, L H Price, et al.
Toxicology and Applied Pharmacology|October 1, 1973
Sensitivity of several serum enzymes for the detection of thioacetamide-, dimethylnitrosamine- and diethanolamine-induced liver damage in ratsG O Korsrud, H G Grice, T K Goodman, et al.
Expert Review of Neurotherapeutics|July 21, 2020
Deep transcranial magnetic stimulation for obsessive compulsive disorderAlexis G McCathern, David S Mathai, Raymond Y Cho, et al.
Journal of Psychiatric Practice|July 7, 2022
Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second EditionGregory S Vogt, Michelle Avendaño-Ortega, Sophie C Schneider, et al.
American Journal of Mental Retardation : AJMR|June 5, 2004
Effects of topiramate in adults with Prader-Willi syndromeNathan A Shapira, Mary C Lessig, Mark H Lewis, et al.
The Journal of Clinical Psychiatry|April 1, 1992
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studiesL C Barr, W K Goodman, L H Price, et al.
Psychopharmacology Bulletin|January 1, 1989
Fluvoxamine as an antiobsessional agentW K Goodman, L H Price, S A Rasmussen, et al.
Psychopharmacology|January 1, 1987
Effects of yohimbine in obsessive compulsive disorderS A Rasmussen, W K Goodman, S W Woods, et al.
The Journal of Clinical Psychiatry|October 1, 1996
Recent developments in neurobiology of obsessive-compulsive disorderM A Jenike, S L Rauch, J L Cummings, et al.
Pageof 53

Showing results (141-150 of 526) with videos related to

Sort By:
Pageof 53
Journal of Obsessive-Compulsive and Related Disorders|February 23, 2022
Obsessive compulsive disorder during the COVID-19 pandemic: A brief review of course, psychological assessment and treatment considerationsCaitlyn E Maye, Katharine D Wojcik, Abigail E Candelari, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1990
Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorderP L Delgado, W K Goodman, L H Price, et al.
Toxicology and Applied Pharmacology|October 1, 1973
Sensitivity of several serum enzymes for the detection of thioacetamide-, dimethylnitrosamine- and diethanolamine-induced liver damage in ratsG O Korsrud, H G Grice, T K Goodman, et al.
Expert Review of Neurotherapeutics|July 21, 2020
Deep transcranial magnetic stimulation for obsessive compulsive disorderAlexis G McCathern, David S Mathai, Raymond Y Cho, et al.
Journal of Psychiatric Practice|July 7, 2022
Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second EditionGregory S Vogt, Michelle Avendaño-Ortega, Sophie C Schneider, et al.
American Journal of Mental Retardation : AJMR|June 5, 2004
Effects of topiramate in adults with Prader-Willi syndromeNathan A Shapira, Mary C Lessig, Mark H Lewis, et al.
The Journal of Clinical Psychiatry|April 1, 1992
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studiesL C Barr, W K Goodman, L H Price, et al.
Psychopharmacology Bulletin|January 1, 1989
Fluvoxamine as an antiobsessional agentW K Goodman, L H Price, S A Rasmussen, et al.
Psychopharmacology|January 1, 1987
Effects of yohimbine in obsessive compulsive disorderS A Rasmussen, W K Goodman, S W Woods, et al.
The Journal of Clinical Psychiatry|October 1, 1996
Recent developments in neurobiology of obsessive-compulsive disorderM A Jenike, S L Rauch, J L Cummings, et al.
Pageof 53